Maintaining control over every link in the cold chain is not just preferredits mandatory
W.H., X.Q.S
Bogers RP, Bemelmans WJ, Hoogenveen RT, Boshuizen HC, Woodward M, Knekt P, van Dam RM, Hu FB, Visscher TL, Menotti A, Thorpe RJ Jr., Jamrozik K, Calling S, Strand BH, Shipley MJ, Investigators B-CC
Observations from PIONEER REAL Netherlands add to those previously reported in the SURE Netherlands study and highlight that both formulations of semaglutide (oral and subcutaneous) can provide clinical improvements in the key management goals (glycaemic control and weight loss) for individuals living with T2D [30]
95% confidence interval [CI], 0.80 to 0.93), myocardial infarction by 13% (HR, 0.87
Introduction Life rarely follows a perfect seven-day cycle